Nuevocor
Singapore
About Nuevocor
Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy-based treatments that have the potential to restore cardiac function in diseased hearts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $80.6M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2025)
- Website: nuevocor.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nuevocor-44443 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.